Pregnancy Clinical Trial
— Quit4BabyOfficial title:
Developing and Scaling a Text Messaging Tool to Help Pregnant Smokers
NCT number | NCT02412865 |
Other study ID # | R44 DA035017-0 2 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | March 31, 2015 |
Last updated | February 25, 2016 |
Start date | April 2015 |
Verified date | February 2016 |
Source | George Washington University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The goal of this project is to evaluate the effectiveness (Phase II) of a text-based program
to be called Quit4Baby to support smoking cessation efforts of pregnant women who smoke.
In Phase II, Dr. Abroms will conduct a randomized clinical trial among 500 pregnant smokers
who have been recruited from users of text4baby - the first large scale mobile health
application in the United States. Developed and operated by Voxiva and Healthy Mothers,
Healthy Babies (HMHB)—collaborators in this program -text4baby is a free national service
that has enrolled more than 800,000 pregnant women and mothers of infants 0-1 nationwide and
delivered more than 150 million health messages to them including messages encouraging them
not to smoke during pregnancy and referring them to quit lines.
Hypothesis 1: Pregnant smokers who receive quit4Baby + text4Baby will demonstrate higher
levels of knowledge about the dangers of second hand smoke and the benefits of smoking
cessation for mothers and their infants than text4baby only users.
Hypothesis 2: Pregnant smokers who receive quit4baby + text4baby will report significantly
higher rates of calling a quit line, discussions with their health provider and/or use of
cessation counseling than those who receive Text4baby alone.
Hypothesis 3: Pregnant smokers who receive quit4baby + text4baby will have significantly
more favorable quitting outcomes compared with text4baby alone.
Status | Completed |
Enrollment | 505 |
Est. completion date | |
Est. primary completion date | February 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 14 Years to 44 Years |
Eligibility |
Inclusion Criteria: 1. Subscribe to the text4baby test messaging program 2. Pregnant 3. Smoke or recently quit (within last 2 weeks)- Smoking will be defined as self-report of smoking at least one cigarette in the past 7 days. Given that these individuals are recruited from text4baby users, we are confident that they will have cell phones and text messaging capacity. 4. Speak English 5. Willing to enroll in our study 6. 14 years old or older Exclusion Criteria: 1. No longer subscribe to text4baby 2. Not pregnant 3. Not current smoker (within past 2 weeks) 4. Non-English speakers 5. Not willing to receive Quit4Baby messages or enroll in study 6. Younger than 14 years of age |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | The George Washington University | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
George Washington University |
United States,
Abroms LC, Johnson PR, Heminger CL, Van Alstyne JM, Leavitt LE, Schindler-Ruwisch JM, Bushar JA. Quit4baby: results from a pilot test of a mobile smoking cessation program for pregnant women. JMIR Mhealth Uhealth. 2015 Jan 23;3(1):e10. doi: 10.2196/mhealth.3846. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Biometrically confirmed abstinence | With saliva cotinine | 3-6 months | No |
Primary | Quitline call rates | 1-6 months | No | |
Primary | Knowledge as measured by survey items | 1-6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A |